SECsense Logo

Bionano Genomics 8-K Filing Insights: Key Events on January 13, 2025

$BNGO
Form 8-K
Filed on: 2025-01-13
Source
Bionano Genomics 8-K Filing Insights: Key Events on January 13, 2025

Based on the provided XML snippet from the financial report, here are the key insights:

  1. Entity Information:
  • Company Name: Bionano Genomics, Inc.
  • CIK (Central Index Key): 0001411690
  • SEC File Number: 001-38613
  • EIN (Employer Identification Number): 26-1756290
  • Address: 9540 Towne Centre Drive, Suite 100, San Diego, CA 92121
  • Contact Number: 858-888-7600
  1. Filing Type:
  • The document is an 8-K filing, which is typically used to report unscheduled material events or corporate changes.
  1. Filing Date:
  • The report is dated January 13, 2025, indicating it is a future filing.
  1. Stock Information:
  • Common Stock: The company has common stock with a par value of $0.0001 per share.
  • Ticker Symbol: BNGO
  • Exchange: The common stock is listed on NASDAQ.
  1. Period of Reporting:
  • The report covers the date of January 13, 2025, suggesting that it may be related to an event or development occurring on that specific date.

Summary:

Bionano Genomics, Inc. is preparing to file an 8-K on January 13, 2025. The company is publicly traded under the ticker BNGO on NASDAQ, with a nominal par value of its common stock at $0.0001 per share. The filing provides essential information about the company, including its CIK, SEC file number, EIN, and contact information. This filing may pertain to a significant event or corporate change that requires timely disclosure to investors.